Synthis Therapeutics, Inc.

Excited to be presenting at the 20th Annual PEGS Boston Meeting on May 16th. I will be giving an oral presentation during the Driving Clinical Success of Antibody Drug Conjugates track. Join us!

All things considered, 2023 was a good year for Synthis Therapeutics. Some highlights: 1. Demonstrated both in vivo efficacy and safety of our lead candidate, SYN101 2. Three issued patents on our platform (US, Japan) 3. Raised a seed extension round 4. Awarded an NHLBI SBIR grant to expand our platform into fibrosis 5. Expanded our SAB to include a TGFb development expert & 2 clinicians with expertise in TGFb clinical trials 6. Presented at 3rd Annual TGFb for ImmunoOncology Drug Develeopment, Life Sciences Summit NYC & 14th Annual World ADC Meeting 7. Won 2023 J&J QuickFire Science in the City Challenge NYC With all the momentum around ADCs, we are excited to see what 2024 has in store!

Exciting ADC times ahead!

It's a good time to be developing novel ADCs!

Excited and humbled to announce that Synthis Therapeutics has won the JnJ Science in the City QuickFire Challenge! This is our 2nd NYC-based early stage/golden ticket award, further validating our strategy and supporting our continued development in this amazing biotech ecosystem. Selected from a large group of applicants, we are thrilled to join the JnJ community and JLABS NYC. Thank you, JnJ, for your support of Synthis and our immunomodulatory ADC therapies! #johnsonandjohnson #jlabs #quickfirechallenge #nycbiotech

Had a blast at 14th Annual World ADC meeting, connecting with old and new friends. ADCs are making its mark in oncology with novel design, interesting payloads and improved cancer care for patients. I’m truly excited to see all the new therapeutic options. Oh and San Diego never disappoints.

We have made significant progress on our immunomodulatory, antibody drug conjugate (ADC), SYN101 and will be sharing recent milestones in a variety of presentations. Come by, say hi and hear what we have been up to! 1. Company Presentation at The Life Sciences Summit 2023, Oct. 11th at 10:15am, Suite 203 at The Alexandria Center for Life Sciences in NYC 2. Poster Presentation at the 14th Annual World ADC Meeting on Oct. 17th, 7pm at Sheraton San Diego Hotel and Marina, CA 3. Company Presentation at NYBio's Mini Pitch Day on November 16th (Time/venue TBD)